- 2022 – 현재: 분자영상학회 회장
- 2021 – 현재: 전남대학교 연구처장, 산학협력단장
- 2020 – 현재: 대한핵의학회 회장
- 2018 – 현재: 아시아 분자영상연합회 Treasurer
- 2018 – 현재: 아시아오세아니아 핵의학회 Board of Directors
- 2018 – 현재: 대한의료인공지능학회 교육이사,홍보이사
- 2017 – 현재: 전남대학교 의과대학 핵의학교실 주임교수
- 2015 – 현재: 전남대학교 분자영상테라노스틱스 연구소 소장
- 2006 – 2018: 화순전남대학교병원 핵의학과 과장
- 2011 – 현재: 전남대학교 의과대학 핵의학교실 교수
- 2006 – 2011: 전남대학교 의과대학 핵의학교실 부교수
- 2004 – 2006: 전남대학교 의과대학 핵의학교실 조교수
- 2003 – 2004: 미국 스탠포드의대 연구원

- 2017 방사선웹진 최우수 연구대상
- 2016 방사선웹진 최우수연구자상
- 2015 핵의학학술상
- 2013 서봉의학상
- 2011 대한핵의학회 학술상(최우수논문상)
- 2008 하이델베르크대학 Hengstberger 심포지움 우수발표자상
- 2006 전남대학교병원 우수논문상
- 2004 대한핵의학회 학술상(우수포스터상)
- 2000 대한핵의학회 학술상(듀퐁상)
- 1998 대한핵의학회 학술상(젊은연구자상)
- 1997 대한핵의학회 학술상(우수포스터상)

- 이사: World Molecular Imaging Society, 대한핵의학회, 분자영상학회
- 정회원: World Molecular Imaging Society, Society of Nuclear Medicine and Molecular Imaging, European Association of Nuclear Medicine, American Advanced Association of Science, American Association of Cancer Research, Radiological Society of North America, IEEE, 대한핵의학회, 분자영상학회, 한국분자세포생물학회, 한국광학회, 대한의사협회

- Kim DY et al. In vivo imaging of invasive aspergillosis with 18 F-fluorodeoxysorbitol positron emisson tomography. Nature Communications 2022 ; 13, 1926
- Kang SR et al. Bacteria and bacterial derivatives as delivery carries for immunotherapy. Advanced Drug Delivery Reviews 2022 Dec 18; 181, 114085
- Pyo A et al. Ultrasensitive detection of malignant melanoma using PET molecular imaging probes. Proceedings of the National Academy of Sciences U S A 2020 June 9; 117, 12991-12999
- Pyo A et al. ⁶⁴Cu-Labeled Repebody Molecules for Imaging of Epidermal Growth Factor Receptor Expressing Tumors. J Nucl Med 2017 Sep 15. [Epub ahead of print]
- Lim D et al. Anti-tumor activity of an immunotoxin (TGFα-PE38) delivered by attenuated Salmonella typhimurium. Oncotarget 2017 Jun 6;8(23):37550-37560.
- Yun MS et al. A High-Affinity Repebody for Molecular Imaging of EGFR-Expressing Malignant Tumors. Theranostics 2017 Jun 25;7(10):2620-2633.
- Zheng JH et al. Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin. Science Translational Medicine 2017 Feb 8;9(376).
- Park SH et al. RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy. Theranostics 2016; 6(10):1672-82.
- Kim JE et al. Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. Theranostics 2015; 5(12): 1328-1342.
- Lee JJ et al. Enzymatic Prenylation and Oxime Ligation for the Synthesis of Stable and Homogeneous Protein-Drug Conjugates for Targeted Therapy. Angew Chem Int Ed Engl 2015 Oct 5;54(41):12020-4.
- Kim DY et al. Comparison of 18F-labeled Fluoroalkylphosphonium Cations with 13N-NH3 for PET Myocardial Perfusion Imaging. J Nucl Med 2015 Oct;56(10):1581-1586
- Jiang SN et al. Engineering of Bacteria for the Visualization of Targeted Delivery of a Cytolytic Anticancer Agent. Molecular Therapy 2013 Nov;21(11):1985-95.
- Kim DY et al. Evaluation of a Mitochondrial Voltage Sensor, (18F-Fluoropentyl) Triphenylphosphonium Cation, in a Rat Myocardial Infarction Model. Journal of Nuclear Medicine 2012 Oct 4;53, 1779-1785
- Le U et al. Engineering and visualization of bacteria for targeting infarcted myocardium. Molecular Therapy 2011;19(5):951-9.
- Sheng-Nan Jiang et al. Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy. Molecular Therapy 2010 Jan 5;(18, 635-642)
- Nguyen VH et al. Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer. Cancer Research 2010;70(1):18-23.
- Min JJ et al. Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals. Nature Protocols 2008;3(4):629-36